Molecular Biology Reports

, Volume 40, Issue 5, pp 3675–3680

Polymorphism in vitamin D receptor and osteoprotegerin genes in Egyptian rheumatoid arthritis patients with and without osteoporosis

  • Yousry Mostafa Hussien
  • Amal Shehata
  • Rehab A. Karam
  • Saad S. Alzahrani
  • Hanem Magdy
  • Abeer M. El-Shafey
Article

Abstract

1α,25-Dihydroxyvitamin D3 upregulates the expression of the receptor activator of nuclear factor kB ligand (RANKL), and downregulates osteoprotegerin (OPG) expression. We tested the effects of polymorphisms in the vitamin D receptor gene (VDR), and OPG gene in rheumatoid arthritis (RA) patients and healthy controls and their relationship to bone mineral density (BMD) and development of osteoporosis. Three hundred and fifty women were evaluated, 200 women having RA and 150 healthy control. The subjects were genotyped for polymorphism at BsmI in VDR and A163G in OPG genes by polymerase chain reaction followed by restriction fragment length polymorphism analysis. BMD was also measured. In A163G, the G allele increased the risk for RA and for the development of osteoporosis. We found a significant association between lower hip (BMD-h) and genotype variants of VDR (BsmI) and OPG A163G in RA patients with osteoporosis. Our results suggested that OPG A163G polymorphism was associated with RA susceptibility and with the development of osteoporosis in these patients. Also, VDR and OPG genes are important candidates for osteoporosis in RA patients.

Keywords

Osteoprotegerin Vitamin D receptor Bone mineral density 

References

  1. 1.
    Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT et al (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581PubMedCrossRefGoogle Scholar
  2. 2.
    Ralston SH, de Crombrugghe B (2006) Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev 20:2492–2506PubMedCrossRefGoogle Scholar
  3. 3.
    Baldock PA, Thomas GP, Hodge, Baker JM, Dressel U, O’Loughlin PD, Nicholson GC, Briffa KH, Gardiner EM (2006) Vitamin D action and regulation of bone remodelling suppression of osteoclastogenesis by the mature osteoblast. J of Bone Miner Res 21:1618–1626CrossRefGoogle Scholar
  4. 4.
    Viitanen A, Karkkainen M, Laitinen K et al (1996) Common polymorphism of the vitamin D receptor gene is associated with variation of peak bone mass in young finns. Calcif Tissue Int 59:231–234PubMedCrossRefGoogle Scholar
  5. 5.
    Sheehan D, Bennett T, Cashman KD (2001) An assessment of genetic markers as predictors of bone turnover in healthy adults. J Endocrinol Invest 24:236–245PubMedGoogle Scholar
  6. 6.
    Ames SK, Ellis KJ, Gunn SK, Copeland KC, Abrams SA (1999) Vitamin D receptor gene Fok1 polymorphism predicts calcium absorption and bone mineral density in children. J Bone Miner Res 14:740–746PubMedCrossRefGoogle Scholar
  7. 7.
    Kondo T, Kitazawa R, Maeda S, Kitazawa S (2004) 1a, 25 Dihydroxyvitamin D3 rapidly regulates the mouse osteoprotegerin gene through dual pathways. J Bone Miner Res 19:1411–1419PubMedCrossRefGoogle Scholar
  8. 8.
    Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, Ingvarsson T (2008) Multiple genetic loci for bone mineral density and fractures. N Engl J Med 358:2355–2365PubMedCrossRefGoogle Scholar
  9. 9.
    Cundy T, Hegde M, Naot D, Chong B, King A, Wallace R, Mulley J (2002) A mutation in the gene TNFRSF11B encoding osteoprotegerin causes idiopathic hyperphosphatasia phenotype. Hum Mol Gen 11:2119–2127PubMedCrossRefGoogle Scholar
  10. 10.
    Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRefGoogle Scholar
  11. 11.
    Prevoo ML, van’t Hof MA, Kuper HH et al (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48PubMedCrossRefGoogle Scholar
  12. 12.
    World Health Organisation (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1–129Google Scholar
  13. 13.
    Chang-Keun L, Jeong-Soo H, You-Sook C, Bin Yoo, Ghi-Su K, Hee-Boom M (2001) Lack of relationship between vitamin D receptor polymorphisms and bone erosion in rheumatoid arthritis. J Korean Med Sci 16:188–192Google Scholar
  14. 14.
    Bente L, Langdahl F, Mette C (2002) Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures. J Bone Miner Res 17:1245–1255CrossRefGoogle Scholar
  15. 15.
    SPSS for Windows (2001) Statistical Package for the Social Sciences, version 11.0 SPSS Inc., ChicagoGoogle Scholar
  16. 16.
    Mencej-Bedrac S, Prezelj J, Kocjan T, Teskac K, Ostanek B, Smelcer M, Marc J (2009) The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density. J Mol Endocrinol 42(3):239–247 Epub 2009 Jan 8PubMedCrossRefGoogle Scholar
  17. 17.
    Ranganathan P (2009) Genetics of bone loss in rheumatoid arthritis–role of vitamin D receptor polymorphisms. Rheumatology (Oxford) 48(4):342–346CrossRefGoogle Scholar
  18. 18.
    Nejentsev S, Godfrey L, Snook H, Rance H, Nutland S, Walker NM, Lam AC, Guja C (2004) Comparative high resolution analysis of linkage disequilibrium and tag single nucleotide polymorphism between populations in the vitamin D receptor gene. Hum Mol Genet 13:1633–1639PubMedCrossRefGoogle Scholar
  19. 19.
    Rass P, Pákozdi A, Lakatos P, Szabo Z, Vegvari A, Szanto S, Szegedi G, Bako G (2006) Vitamin D receptor gene polymorphism in rheumatoid arthritis and associated osteoporosis. Rheumatol Int 26:964–971PubMedCrossRefGoogle Scholar
  20. 20.
    Sung KL, Young SP, Jae MP (1995) Lack of association between vitamin D receptor genotypes and osteoporosis in Korean. J Clin Endocrinol Metab 80:116–120CrossRefGoogle Scholar
  21. 21.
    Lisker R, López M, Jasqui S, de León Ponce, Rosales S, Correa-Rotter R, Sanchez S (2003) Association of vitamin D receptor polymorphisms with osteoporosis in Mexican postmenopausal women. Hum Biol 75:399–403PubMedCrossRefGoogle Scholar
  22. 22.
    Horst-Sikorska W, Wawrzyniak A, Celczyńska-Bajew L, Marcinkowska M, Dabrowski S, Kalak R, Słomski R (2005) Polymorphism of VDR gene-the most effective molecular marker of osteoporotic bone fractures risk within postmenopausal women from Wielkopolska region of Poland. Pol J Endocrinol 3:233–239Google Scholar
  23. 23.
    Langdahl BL, Carstens M, Stenkjaer L, Eriksen EF (2002) Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures. J Bone Miner Res 17:1245–1255PubMedCrossRefGoogle Scholar
  24. 24.
    Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P, Eisman JA, Fujiwara S, Kroger H, Mellstrom D, Meunier PJ, J.Melton L III, O’Neill T, Pols H, Reeve J, Silman A, Tenenhouse A (2005) Predictive value of BMD for hip and other fractures. J Bone Miner Res 20:1185–1194PubMedCrossRefGoogle Scholar
  25. 25.
    Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA (1994) Prediction of bone density from vitamin D receptor alleles. Nature 367:284–287PubMedCrossRefGoogle Scholar
  26. 26.
    Efstathiadou Z, Kranas V, Ioannidis JP, iadou Z, Georgiou I, Tsatsoulis A (2001) COLIA1 gene polymorphism, and not vitamin D receptor or estrogen receptor gene polymorphisms, determines bone mineral density in postmenopausal Greek women. Osteoporos Int 12:326–331PubMedCrossRefGoogle Scholar
  27. 27.
    Fang Y, Van Meurs JB, Bergink AP, Hofman A, Van Duijn CM, van Leeuwen JP (2003) Cdx-2 polymorphism in the promoter region of the human vitamin D receptor gene determines susceptibility to fracture in the elderly. J Bone Miner Res 18:1632–1641PubMedCrossRefGoogle Scholar
  28. 28.
    Jorgensen HL, Kusk P, Madsen B, Fenger M, Lauritzen JB (2004) Serum osteoprotegerin (OPG) and A163G polymorphism in the OPG promotor region to peripheral measures of bone mass and fracture odds ratio. J Bone Miner Metab 22:132–138PubMedCrossRefGoogle Scholar
  29. 29.
    Hsiang-Yi H, Tianhua N, Henry A (2006) Variation in genes involved in the RANKL/RANK/OPG bone remodelling pathway are associated with bone mineral density at different skeletal sites in men. Hum Genet 118:568–577CrossRefGoogle Scholar
  30. 30.
    Vidal C, Brincat M, Xuereb A (2006) TNFRSF11B gene variants and bone mineral density in postmenopausal women in Malta. Maturitas 53:386–395PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2012

Authors and Affiliations

  • Yousry Mostafa Hussien
    • 1
    • 2
  • Amal Shehata
    • 1
  • Rehab A. Karam
    • 1
  • Saad S. Alzahrani
    • 3
  • Hanem Magdy
    • 1
  • Abeer M. El-Shafey
    • 4
  1. 1.Department of Medical Biochemistry, Faculty of MedicineZagazig UniversityZagazigEgypt
  2. 2.Medical Laboratories Department Faculty of Applied Medical SciencesTaif UniversityTaifKingdom of Saudi Arabia
  3. 3.Family Medicine Department, Faculty of Applied Medical SciencesTaif UniversityTaifKingdom of Saudi Arabia
  4. 4.Rheumatology and Rehabilitation Department, Faculty of MedicineZagazig UniversityZagazigEgypt

Personalised recommendations